JPRN-UMIN000032667已完成未知
Retrospective observational study of salvage chemotherapy following nivolumab therapy in advanced non-small cell lung cancer - Retrospective exploratory study of salvage chemotherapy for nivolumab-refractory lung cancer
Department of Respiratory Medicine, Sasebo City General Hospital0 个研究点目标入组 15 人开始时间: 2018年6月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
Both few PD-1 positive immune cells in the tumor and decreased NLR ratio during the treatment may predict the improved response to salvage chemotherapy following nivolumab for lung cancer.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The patients are excluded from the analysis if they had another neoplasm for the need of treatment, and if they received the preceding therapy of EGFR or ALK throsine kinase inhibitors before or after nivolumab therapy.
研究者
相似试验
进行中（未招募）
不适用
The influence of immunotherapy and chemotherapy accompanying endurance training on incidence and severity of cognitive deficits as well as other therapy-induced side effects and complications in oncological patients. A randomized controlled trialDIVERSEC00-C75Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissueDRKS00011390niversitäres Centrum für Tumorerkrankungen (UCT) FrankfurtKrankenhaus NordwestKlinik für Onkologie und Hämatologie2
已完成
1 期
A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast CancerBreast CancerNCT02999477Adrienne G. Waks32
Unknown
1 期
Nivolumab and Eribulin in HER2 Negative Metastatic Breast CancerMetastatic Breast CancerNCT04061863Seoul National University Hospital90
尚未招募
2 期
In patients with the cancer called Hodgkins lymphoma we are trying to see whether adding a medicine stimulating the immune system will increase the benefit of usual treatmentCTRI/2023/11/060108Jawaharlal Institute of Postgraduate Medical Education and Research JIPMER
终止
2 期
Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC).Fallopian Tube CancerPeritoneum CancerEpithelial Ovarian CancerNCT02834975University of Miami26